Jinling Pharmaceutical Co.,Ltd.’s Net Profit Rose 1.4% in First Three Quarters of 2023

Jinling Pharmaceutical Co.,Ltd. (金陵药业股份有限公司) (000919.SZ) reported a net profit of 106.9 million yuan in the first three quarters of 2023, up 1.4% year-on-year.

Meanwhile, the company posted 2.1 billion yuan in revenue, up 2.5% year-on-year.

At the end of the reporting period, it had 4.5 billion yuan in total assets and 859.4 million yuan in total liabilities, with a liability-to-asset ratio of 18.9%.